Mural Capital Lease Obligations vs Non Current Assets Total Analysis
| MURA Stock | 3.44 0.20 5.49% |
Mural Oncology financial indicator trend analysis is infinitely more than just investigating Mural Oncology plc recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Mural Oncology plc is a good investment. Please check the relationship between Mural Oncology Capital Lease Obligations and its Non Current Assets Total accounts. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mural Oncology plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area.
Capital Lease Obligations vs Non Current Assets Total
Capital Lease Obligations vs Non Current Assets Total Correlation Analysis
The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Mural Oncology plc Capital Lease Obligations account and Non Current Assets Total. At this time, the significance of the direction appears to have almost identical trend.
The correlation between Mural Oncology's Capital Lease Obligations and Non Current Assets Total is 0.95. Overlapping area represents the amount of variation of Capital Lease Obligations that can explain the historical movement of Non Current Assets Total in the same time period over historical financial statements of Mural Oncology plc, assuming nothing else is changed. The correlation between historical values of Mural Oncology's Capital Lease Obligations and Non Current Assets Total is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Capital Lease Obligations of Mural Oncology plc are associated (or correlated) with its Non Current Assets Total. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Non Current Assets Total has no effect on the direction of Capital Lease Obligations i.e., Mural Oncology's Capital Lease Obligations and Non Current Assets Total go up and down completely randomly.
Correlation Coefficient | 0.95 |
| Relationship Direction | Positive |
| Relationship Strength | Very Strong |
Capital Lease Obligations
Mural Oncology plc capital lease obligations are the amount due for long-term lease agreements that are nearly equivalent to Mural Oncology asset purchases. For example, Mural Oncology can use a capital lease to finance the purchase of an asset without ever buying it. A capital lease gives companies such as Mural Oncology control over an asset for a big portion of its life. The total obligations of a company under capital leases, which are lease agreements that transfer substantially all risks and rewards of ownership to the lessee.Non Current Assets Total
The total value of a company's long-term assets, which are not expected to be converted into cash or used up within one year or the operating cycle, including property, plant, and equipment, and intangible assets.Most indicators from Mural Oncology's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Mural Oncology plc current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mural Oncology plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. At present, Mural Oncology's Enterprise Value Over EBITDA is projected to increase slightly based on the last few years of reporting. The current year's Enterprise Value Multiple is expected to grow to 0.86, whereas Tax Provision is forecasted to decline to about 6.3 M.
| 2010 | 2022 | 2023 | 2024 (projected) | Depreciation And Amortization | 1.5M | 1.5M | 2.6M | 2.0M | Tax Provision | 68K | 4.9M | 12.2M | 6.3M |
Mural Oncology fundamental ratios Correlations
Click cells to compare fundamentals
Mural Oncology Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.When determining whether Mural Oncology plc offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Mural Oncology's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Mural Oncology Plc Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Mural Oncology Plc Stock:Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in Mural Oncology plc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in metropolitan statistical area. You can also try the Stock Tickers module to use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Mural Oncology. If investors know Mural will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Mural Oncology listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (9.03) | Return On Assets (0.81) | Return On Equity (1.78) |
The market value of Mural Oncology plc is measured differently than its book value, which is the value of Mural that is recorded on the company's balance sheet. Investors also form their own opinion of Mural Oncology's value that differs from its market value or its book value, called intrinsic value, which is Mural Oncology's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Mural Oncology's market value can be influenced by many factors that don't directly affect Mural Oncology's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Mural Oncology's value and its price as these two are different measures arrived at by different means. Investors typically determine if Mural Oncology is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Mural Oncology's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.